Heron Therapeutics, Inc. (HRTX): Total Assets
$255.88M
As of 2025-12-31
$252.26M
As of 2026-06-30
+0.7%
3-year compound annual growth
-6.3%
5-year compound annual growth
+6.4%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $255.88M | +9.7% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $233.15M | +4.8% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $222.51M | -11.3% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $250.95M | -17.9% | 2024-03-12, Balance as of period end |
| 2021-12-31 | $305.71M | -13.5% | 2023-03-29, Balance as of period end |
| 2020-12-31 | $353.56M | -31.1% | 2022-02-28, Balance as of period end |
| 2019-12-31 | $512.78M | +10.9% | 2021-02-24, Balance as of period end |
| 2018-12-31 | $462.18M | +97.3% | 2020-03-02, Balance as of period end |
| 2017-12-31 | $234.31M | +247.2% | 2019-02-22, Balance as of period end |
| 2016-12-31 | $67.48M | -51.0% | 2018-02-27, Balance as of period end |
| 2015-12-31 | $137.84M | +79.8% | 2017-02-23, Balance as of period end |
| 2014-12-31 | $76.68M | +1.0% | 2016-02-19, Balance as of period end |
| 2013-12-31 | $75.94M | +35.7% | 2015-03-13, Balance as of period end |
| 2012-12-31 | $55.97M | +187.8% | 2014-03-07, Balance as of period end |
| 2011-12-31 | $19.45M | +568.0% | 2013-03-01, Balance as of period end |
| 2010-12-31 | $2.91M | n/a | 2012-03-26, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | $255.88M | +9.7% |
| Liquidia Corp (LQDA) | 2025-12-31 | $327.93M | +42.4% |
| Macrogenics Inc (MGNX) | 2025-12-31 | $256.85M | -1.8% |
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $138.29M | +43.5% |
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | $108.42M | -34.1% |
| Syndax Pharmaceuticals Inc (SNDX) | 2025-12-31 | $529.71M | -26.9% |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | $259.15M | -31.5% |
| Cryoport, Inc. (CYRX) | 2025-12-31 | $764.99M | +8.7% |
| Lifevantage Corp (LFVN) | 2026-06-30 | $62.11M | -13.7% |
Compare HRTX, LQDA, MGNX, ELTP side by side · Screen every company in Pharmaceutical Preparations ↗